Cargando…
Generic antibiotic industries: Challenges and implied strategies with regulatory perspectives
Ever since the discovery of antibiotics, the quality of human life greatly improved in the 20(th) century. The discovery of penicillin transformed the medicine industry and initiated a search for a better antibiotic every time resulting in several synthetic and semi-synthetic antibiotics. Beginning...
Autores principales: | Venkatesh, M., Bairavi, V. G., Sasikumar, K. C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3053506/ https://www.ncbi.nlm.nih.gov/pubmed/21430959 http://dx.doi.org/10.4103/0975-7406.76481 |
Ejemplares similares
-
Heartworm disease – Overview, intervention, and industry perspective
por: Noack, Sandra, et al.
Publicado: (2021) -
Antiretroviral generics
por: Andrieu, Véronique
Publicado: (2012) -
Requirements for generic anti-epileptic medicines: a regulatory perspective
por: Maliepaard, Marc, et al.
Publicado: (2009) -
The varicocele: diagnostic dilemmas, therapeutic challenges and future perspectives
por: Chiba, Koji, et al.
Publicado: (2016) -
Licensing of Generic Medicines: Are There Any Challenges Left? A Pharmaceutical Regulatory Perspective
por: Borg, John Joseph, et al.
Publicado: (2014)